Centipeda minima (Ebushicao) extract inhibits PI3K-Akt-mTOR signaling in nasopharyngeal carcinoma CNE-1 cells

BACKGROUND: Centipeda minima (Ebushicao) has been used for the treatment of various diseases, such as nasal allergies, rhinitis and sinusitis, nasopharyngeal carcinoma, cough, and headache. This study aims to investigate the anticancer activities of Centipeda minima ethanol extracts (CME) against na...

Full description

Saved in:
Bibliographic Details
Published in:Chin Med
Main Authors: Guo, Yu-qing, Sun, Hai-yan, Chan, Chi-on, Liu, Bei-bei, Wu, Jian-hong, Chan, Shun-wan, Mok, Daniel Kam-Wah, Tse, Anfernee Kai-Wing, Yu, Zhi-ling, Chen, Si-bao
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575463/
https://ncbi.nlm.nih.gov/pubmed/26388933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13020-015-0058-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items